Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme

Peer Review reports

Original Submission
12 Jan 2009	Submitted	Original manuscript
21 Jan 2009	Author responded	Author comments - Taina Taskila
Resubmission - Version 2
21 Jan 2009	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
26 Jan 2009	Author responded	Author comments - Taina Taskila
Resubmission - Version 4
26 Jan 2009	Submitted	Manuscript version 4
Publishing
28 Jan 2009	Editorially accepted
28 Jan 2009	Article published	10.1186/1471-2407-9-36

Back to article page